BUZZ-Valeant Pharmaceuticals International Inc: Hits over 2-year low

Thu Nov 5, 2015 11:03am EST
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

** Beleaguered drugmaker's shares down 16 pct at $77.67 after briefly hitting over 2-year low

** A U.S. Senate panel launched on Wednesday a bipartisan probe into pharmaceutical pricing, seeking documents from 4 drugmakers including Valeant and Turing Pharmaceuticals, companies embroiled in controversy over price hikes on lifesaving drugs

** Valeant shareholder Bill Ackman said he told a company board member that longtime CEO Michael Pearson may have to go, Wall Street Journal reported (

** Graphic:

** Up to Wednesday's close, Valeant had lost nearly two-thirds of its market value since its stock hit year-high on Aug. 6